参考文献/References:
[1] 中华医学会骨质疏松和骨矿盐疾病分会.原发性骨质疏松症诊治指南(2011年)[J].中华骨质疏松和骨矿盐疾病杂志,2011,4(1):2-17.
[2] 陈瑾瑜,游利,潘凌,等.老年患者脆性骨折1072例分析[J].世界临床药物,2016,37(6):385-389.
[3] 黄淑纾,林华,朱秀芬,等.骨质量与骨质疏松性骨折[J].中华骨质疏松和骨矿盐疾病杂志,2012,5(4):285-291.
[4] MORI S.Contribution of bone quality to fracture risk[J].Clin Calcium,2004,14(10):33-38.
[5] 王桂华.骨质量的影响因素及其检测方法[J].医学研究生学报,2011,24(10):1095-1098.
[6] 郭世绂.骨质量与骨质疏松症[J].国外医学(内分泌学分册),2005,25(5):295-297.
[7] 黄立莉,洪文,王立源,等.绝经后骨质疏松症的临床治疗进展[J].中国医药导报,2011,8(18):7-10.
[8] 王鸥,邢小平.老年性骨质疏松症发病机制及药物治疗进展[J].中国实用内科杂志,2011,31(8):584-586.
[9] 杨涛涛,吕晓红,任凤华,等.老年骨质疏松性骨折患者的危险因素与干预措施[J].现代预防医学,2012,39(11):2756-2757.
[10] 宁娟.老年骨质疏松性骨折患者的危险因素与护理干预措施[J].中国卫生产业,2012,9(10):32-33.
[11] KANIS JA,BORGSTROM F,DE LAET C,et al.Assessment of fracture risk[J].Osteoporos Int,2005,16(6):581-589.
[12] KANIS JA,JOHNELL O,ODEN A,et al.FRAX and the assessment of fracture probability in men and women from the UK[J].Osteoporos Int,2008,19(4):385-397.
[13] RAJAMANOHARA R,ROBINSON J,RYMER J,et al.The effect of weight and weight change on the long-term precision of spine and hip DXA measurements[J].Osteoporos Int,2011,22(5):1503-1512.
[14] 杨丹,粟平,赵平.探讨骨质疏松性骨折的相关影响因素及预防[J].中国骨质疏松杂志,2014,20(2):152-155.
[15] 邓介超,唐海,朱富强,等.FRAX在中国绝经后女性人群骨折风险预测中的适用性评价[J].中华骨质疏松和骨矿盐疾病杂志,2012,5(4):247-254.
[16] 张智海,高冰,刘忠厚.应用骨折风险因子评估工具(FRAX)诊治骨质疏松症[J].中国骨质疏松杂志,2012,18(7):589-595.
[17] 朱再胜,章振林.骨折风险评估工具(FRAX(R))对绝经后低骨量女性骨折的预测价值[J].中华骨质疏松和骨矿盐疾病杂志,2013,6(3):213-218.
[18] 冯颖瑜.骨质疏松症的药物治疗[J].医学综述,2014,20(1):105-109.
[19] 廖二元.骨质疏松防治的现状与进展[J].药品评价,2013,10(5):15-21.
[20] 中华医学会骨质疏松和骨矿盐疾病分会,中华医学会骨科学分会骨质疏松学组.骨质疏松性骨折患者抗骨质疏松治疗与管理专家共识[J].中华骨质疏松和骨矿盐疾病杂志,2015,8(3):189-195.
[21] 李国德.骨质疏松症的中医药治疗概述[J].中国老年保健医学,2010,8(4):69-70.
[22] 彭丽红,马改霞.骨质疏松症的中医药治疗研究进展[J].西北药学杂志,2013,28(1):98-101.
[23] 严红梅,张振海,孙娥,等.中药治疗骨质疏松症的研究进展[J].中草药,2014,45(8):1174-1178.
[24] 李春雯,毛应德龙,史晓林.强骨饮对去势大鼠股骨颈骨形态计量学的影响[J].中国骨质疏松杂志,2007,13(6):433-435.
相似文献/References:
[1]韩艳,温利平,刘娜,等.补肾活血方对去卵巢大鼠骨代谢及骨密度的影响[J].中医正骨,2015,27(12):7.
HAN Yan,WEN Liping,LIU Na,et al.Effect of Bushen Huoxue Fang(补肾活血方)on bone metabolism and bone mineral density in the ovariectomized rats[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(05):7.
[2]徐伟锋,叶健,吴连国.强骨饮对骨质疏松性股骨颈骨折患者全髋关节置换术后
血清骨代谢生化指标和骨密度的影响[J].中医正骨,2015,27(02):12.
XU Weifeng,YE Jian,WU Lianguo.Effect of Qianggu Yin(强骨饮,QGY)on serum bone metabolism indexes and bone density after total hip arthroplasty in patients with osteoporotic femoral neck fractures[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(05):12.
[3]龚江浩.股骨近端防旋髓内钉联合抗骨质疏松药物治疗
不稳定型老年股骨转子间骨折的临床观察[J].中医正骨,2015,27(04):29.
GONG Jianghao.A combination therapy of proximal femoral nail antirotation and anti-osteoporotic drugs for the treatment of unstable femoral intertrochanteric fractures in the aged[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(05):29.
[4]潘雄,刘其顺,应行,等.中药联合4步康复锻炼法对骨质疏松性椎体压缩
骨折患者生存质量的影响[J].中医正骨,2015,27(04):65.
[5]陈建德,樊晓琦,夏炳江,等.球囊扩张部位对椎体后凸成形术治疗骨质疏松性椎体压缩骨折疗效及安全性的影响[J].中医正骨,2017,29(02):11.
CHEN Jiande,FAN Xiaoqi,XIA Bingjiang,et al.Influence of balloon dilation position on curative effect and safety of percutaneous kyphoplasty for treatment of osteoporotic vertebral compression fractures[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2017,29(05):11.
[6]施振宇,刘钟,陈文亮,等.中医综合疗法防治绝经后骨量减少的多中心临床研究[J].中医正骨,2017,29(04):1.
SHI Zhenyu,LIU Zhong,CHEN Wenliang,et al.A multicenter clinical study of complex therapy of traditional Chinese medicine for prevention and treatment of postmenopausal osteopenia[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2017,29(05):1.
[7]陈勍,刘钟,陈文亮,等.股骨近端防旋髓内钉固定联合口服仙灵骨葆胶囊治疗肾阳虚型骨质疏松性股骨转子间骨折[J].中医正骨,2017,29(07):69.
[8]曾武,林曙峰,朱俊峰,等.女性骨质疏松性桡骨远端骨折锁定钢板内固定术后腕关节功能恢复的影响因素分析[J].中医正骨,2017,29(08):39.
ZENG Wu,LIN Shufeng,ZHU Junfeng,et al.Analysis of factors influencing wrist function recovery after locking plate internal fixation for treatment of osteoporotic distal radius fractures in female[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2017,29(05):39.
[9]孙龙泰,姚华海,王晓洛,等.强骨饮对假体周围骨溶解模型大鼠骨密度的影响及其作用机制研究[J].中医正骨,2017,29(09):19.
SUN Longtai,YAO Huahai,WANG Xiaoluo,et al.Effect of Qianggu Yin(强骨饮)on bone density of peri-prosthetic osteolysis rat models and its mechanism of action[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2017,29(05):19.
[10]梁文娜,李西海,胡柳,等.二至丸抑制绝经后骨质疏松大鼠骨代谢紊乱的作用机制研究[J].中医正骨,2017,29(11):1.
LIANG Wenna,LI Xihai,HU Liu,et al.Study on mechanism of action of Erzhi Wan(二至丸)in inhibiting bone metabolism disorder in rats with postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2017,29(05):1.
[11]宋永枝,陈双玲.唑来膦酸静脉滴注联合鲑降钙素肌肉注射治疗
骨质疏松性长骨骨折[J].中医正骨,2016,28(01):70.
[12]吴鹏,王博,孔令成,等.强骨饮颗粒联合阿仑膦酸钠维D3片口服在原发性骨质疏松性髋部骨折术后抗骨质疏松治疗中的应用[J].中医正骨,2016,28(05):16.
WU Peng,WANG Bo,KONG Lingcheng,et al.Oral application of Qiangguyin Keli(强骨饮颗粒)and alendronate sodium Vitamin D3 tablets in postoperative anti-osteoporosis treatment in patients with primary osteoporotic hip fractures[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(05):16.
[13]黄俊俊,史晓林,邓祖跃.强骨饮对骨质疏松性骨折愈合的影响及其作用机制[J].中医正骨,2018,30(09):10.
HUANG Junjun,SHI Xiaolin,DENG Zuyue.Effects of Qianggu Yin(强骨饮)on the healing of osteoporotic fracture and its mechanism of action[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2018,30(05):10.